Antibody drug conjugates (ADCs) represent a transformative approach to modern cancer treatment; over the years, this upcoming class of targeted therapeutic agents has generated significant enthusiasm within the medical science community
The recent surge inthe demand of radiopharmaceuticals for diagnostic and therapeutic applications,coupled with the introduction of theranostics, has opened up opportunities forcompanies having capabilities to manufacture nuclear medicine and radiopharmace...
A steadily growing demand for biologic fill / finish services has generated a range of new opportunities for contract service providers; stakeholders have invested heavily to ensure product integrity and safety
Roots Analysis has done a detailed report on Subcutaneous Biologics, Technologies and Drug Delivery Systems (3rd Edition), 2020-2030” covering key aspects of the industry and identifying future growth opportunities
Subcutaneous drug delivery, giventhe use of tailored formulation development solutions, has brought about aparadigm shift in at-home healthcare, enabling users to administer(life-saving) medications without having to rely on medical professionals